Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Autolus Therapeutics (AUTL) Shares Issued (2022 - 2024)

Autolus Therapeutics (AUTL) has disclosed Shares Issued for 2 consecutive years, with $7000.0 as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Shares Issued changed N/A year-over-year to $7000.0, compared with a TTM value of $7000.0 through Sep 2025, down 98.82%, and an annual FY2024 reading of $602000.0, changed N/A over the prior year.
  • Shares Issued was $7000.0 for Q4 2024 at Autolus Therapeutics, up from -$549.4 million in the prior quarter.
  • Across five years, Shares Issued topped out at $550.0 million in Q1 2024 and bottomed at -$549.4 million in Q3 2024.